Skip to main content

Table 5 Effect of OSS training on facility performance in each of the IMID-MLP and No-IMID groups

From: Effectiveness of educational outreach in infectious diseases management: a cluster randomized trial in Uganda

Ind no. Indicator Overall (n = 669,580) No-IMID (n = 543,119) IMID-MLP (n = 126,461)
aRRR (99 % CI) p-value aRRR (99 % CI) p-value aRRR (99 % CI) p-value
1 Proportion of outpatients triaged *1.67 (0.88, 3.16) 0.04 *1.68 (0.90, 3.16) 0.03 1.65 (0.63, 4.31) 0.18
2 Proportion of emergency and priority patients who were admitted, detained or referred *2.00 (0.93, 4.27) 0.02 **2.12 (1.05, 4.28) 0.006 1.31 (0.63, 2.72) 0.34
3 Estimated proportion of emergency patients who received at least one appropriate treatment **2.00 (1.11, 3.79) 0.003 **1.98 (1.21, 3.24) 0.000 *2.15 (0.83, 5.54) 0.04
4 Proportion of malaria suspects with a malaria test result recorded 1.21 (0.86, 1.69) 0.15 1.21 (0.81, 1.82) 0.22 1.21 (0.80, 1.81) 0.24
5 Estimated proportion of malaria cases who received an appropriate antimalarial **1.15 (1.01, 1.32) 0.006 *1.12 (0.99, 1.27) 0.011 **1.26 (1.02, 1.56) 0.005
6 Proportion of patients with a negative malaria test result who were prescribed an antimalarial **0.65 (0.44, 0.98) 0.006 0.75 (0.48, 1.18) 0.10 **0.49 (0.26, 0.92) 0.004
7 Proportion of patients with a positive malaria test result who were prescribed an antibiotic 0.94 (0.78, 1.13) 0.37 0.92 (0.77, 1.09) 0.20 1.13 (0.66, 1.96) 0.55
8 Proportion of pneumonia suspects aged under 5 years assessed for pneumonia 1.05 (0.35, 3.15) 0.90 0.94 (0.32, 2.78) 0.89 1.21 (0.37, 4.03) 0.68
9 Estimated proportion of patients aged under 5 years diagnosed with pneumonia who received appropriate antibiotic treatment 0.95 (0.57, 1.58) 0.80 0.96 (0.59, 1.15) 0.83 0.95 (0.54, 1.69) 0.84
10 Proportion of TB suspects with a first Acid-Fast Bacilli (AFB) smear result 1.03 (0.45, 2.38) 0.92 0.94 (0.39, 2.28) 0.88 1.19 (0.44, 3.17) 0.66
11 Estimated proportion of patients with AFB smear negative results who received empiric treatment for acute respiratory infection *1.76 (0.93, 3.32) 0.023 1.58 (0.82, 3.03) 0.07 **2.04 (1.06, 3.94) 0.005
16 Proportion of patients with an HIV test result recorded (all patients ≥2 months) 1.20 (0.73, 1.96) 0.35 1.10 (0.64, 1.87) 0.66 1.48 (0.84, 2.61) 0.07
  1. **Denotes that the effect of OSS was significant at the .01 level and *Denotes that the effect of OSS was significant at the .05 level
  2. The 99% confidence intervals (CI) are based on the .01 level of significance
  3. Abbreviations: aRRR adjusted ratio of relative risk, IMID Integrated Management of Infectious Disease, OSS On-site support, MLP Mid-level practitioners, AFB Acid-fast bacilli, HIV HumanImmunodeficiency Syndrome, TB Tuberculosis
  4. aRRR adjusted Ratio of Relative Risk measured the effect of OSS in each subgroup
  5. Estimates were adjusted for: whether the facility received the on-site intervention from Baylor International Pediatric AIDS Initiative or not, facility was implementing continuous quality improvement prior to IDCAP trial, level of health facility (small hospital or health center IV), facility ownership (public or private-not-for profit) and data entry assistant on-site